Calcification of vascular smooth muscle cell cultures: Inhibition by osteopontin

Circulation Research

Volumn 84, Issue 2, 1999, Pages 166-178

  Wada, Takeo ^a   McKee, Marc D ^b   Steitz, Susie ^a   Giachelli, Cecilia M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Osteopontin; Smooth muscle cell; Ultrastructure; Vascular calcification; Vascular disease

Indexed keywords

ALKALINE PHOSPHATASE; FIBRONECTIN; GLYCEROL 2 PHOSPHATE; LEVAMISOLE; NEUTRALIZING ANTIBODY; OSTEOPONTIN; VITRONECTIN;

ANIMAL MODEL; ANIMAL TISSUE; AORTA STENOSIS; ARTICLE; ATHEROSCLEROSIS; CALCIFICATION; CELL ADHESION; CELL CULTURE; CELL ULTRASTRUCTURE; CHELATION; ENZYME INHIBITION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HISTOCHEMISTRY; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS; VASCULAR SMOOTH MUSCLE;

EID: 0033524663     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.84.2.166     Document Type: Article

References (58)

1. Cotran RS, Kumar V, Robbins SL. Cellular injury and cellular death. In: Robbins SL, ed. Pathological Basis of Disease. 5th ed. Philadelphia, Pa: W.B. Saunders Co; 1994:1-35.
2. Schoen FJ, Levy RJ, Piehler HR. Pathological considerations in replacement cardiac valves. Cardiovasc Pathol. 1992;1:29-52.
3. Beadenkopf WG, Daoud AS, Love BM. Calcification in the coronary arteries and its relationship to arteriosclerosis and myocardial infarction. AJR Am J Roentgenol. 1964;92:865-871.
4. Niskanen LK, Suhonen M, Siitonen O, Lehtinen JM, Uusitupa MI. Aortic and lower limb artery calcification in type II (non-insulin-dependent) diabetic patients and non-diabetic control subjects. A five year follow-up study. Atherosclerosis. 1990;84:61-71.
5. Fitzgerald PJ, Ports TA, Yock PG. Contribution of localized calcium deposits to dissection after angioplasty: an observational study using intravascular ultrasound. Circulation. 1992;86:64-70.
6. Locker TH, Schwanz RS, Cotta CW, Hickman JR. Fluoroscopic coronary artery calcification and associated coronary disease in asymptomatic young men. J Am Coll Cardiol. 1992;19:1167-1172.
7. Puentes G, Detrano R, Tang W, Wong N, French W, Narahara K, Brundage B, Baksheshi H. Estimation of coronary calcium mass using electron beam computed tomography: a promising approach for predicting coronary events? Circulation. 1995;92(suppl 1):I-313. Abstract.
8. Kim KM. Calcification of matrix vesicles in human aortic valve and aortic media. Fed Proc. 1976;35:156-162.
9. Tanimura A, McGregor DH, Anderson HC. Calcification in atherosclerosis, I: human studies. J Exp Pathol. 1986;2:261-272.
10. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest. 1993;91:1800-1809.
11. Keeley FW. The extraction and partial characterization of proteins released by decalcification from calcified human aortic plaques. Biochim Biophys Acta. 1977;494:384-394.
12. Levy RJ, Howard SL, Oshry LJ. Carboxyglutamic acid (Gla) containing proteins of human calcified atherosclerotic plaque solubilized by EDTA. Atherosclerosis. 1986;59:155-160.
13. Shanahan CM, Weissberg PL, Metcalfe JC. Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res. 1993;73:193-204.
14. Shanahan CM, Cary NRB, Metcalfe JC, Weissberg PL. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest. 1994;93:2393-2402.
15. Fleet JC, Hock JM. Identification of osteocalcin mRNA in nonosteroid tissue of rats and humans by reverse transcription-polymerase chain reaction. J Bone Miner Res. 1994;9:1565-1573.
16. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR. Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 1997;386:78-81.
17. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest. 1993;92:1686-1696.
18. O'Brien ER, Garvin MR, Stewart DK, Hinohara T, Simpson JB, Schwartz SM, Giachelli CM. Osteopontin is synthesized by macrophages, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb. 1994;14:1648-1656.
19. O'Brien KD, Kuusisto J, Reichenbach DD, Ferguson M, Giachelli CM, Alpers CE, Otto CM. Osteopontin is expressed in human aortic valvular lesions: evidence that aortic valve calcification may be actively regulated. Circulation. 1995;92:2163-2168.
20. Ikeda T, Shirasawa T, Esaki Y, Yoshiki S, Hirokawa K. Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J Clin Invest. 1993;92:2814-2820.
21. Hirota S, Imakita M, Kohri K, Ito A, Morii E, Adachi S, Kim H-M, Kitamura Y, Yutani C, Nomura S. Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques: a possible association with calcification. Am J Pathol. 1993;143:1003-1008.
22. Fitzpatrick LA, Severson A, Edwards WD, Ingram RT. Diffuse calcification in human coronary arteries: association of osteopontin with atherosclerosis. J Clin Invest. 1994;94:1597-1604.
23. Giachelli CM, Schwartz SM, Liaw L. Molecular and cellular biology of osleopontin: potential role in cardiovascular disease. Trends Cardiovasc Med. 1995;5:88-95.
24. Butler WT, Ridall AL, McKee MD. Osteopontin. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of Bone Biology. San Diego, Calif: Academic Press; 1996:167-181.
25. Boskey AL, Maresca M, Ullrich W, Doty SB, Butler WT, Prince CW. Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Miner. 1993;22: 147-159.
26. Hunter GK, Kyle CL, Goldberg HA. Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin mediated inhibition of hydroxyapatite formation. Biochem J. 1994;300:723-728.
27. Ross FP, Chappel J, Alvarez JI, Sander D, Butler WT. Farach-Carson MC, Mintz KA, Robey PG, Teitelbaum SL, Cheresh DA. Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin αvβ3 potentiate bone resorption. J Biol Chem. 1993;268:9901-9907.
28. Shioi A, Nishizawa Y, Jono S, Koyama H, Hosoi M, Morii H. B-giycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1995;15: 2003-2009.
29. Ross R. The smooth muscle cell, II: growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol. 1971;50:172-186.
30. Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res. 1994;74:214-224.
31. Frid MG, Shekhonin BV, Koteliansky VE, Glukhova MA. Phenotypic changes of human smooth muscle cells during development: late expression of heavy caldesmon and calponin. Dev Biol. 1992;153: 185-193.
32. Mallory FB. Pathological Techniques. 2nd ed. Philadelphia, Pa: W.B. Saunders Co; 1942.
33. Jono S, Nishizawa Y, Shioi A, Morii H. Parathyroid hormone-related peptide as a local regulator of vascular calcification: its inhibitory action on in vitro calcification by bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1997;17:1135-1142.
34. Bessey OA, Lowry OH, Brock MJ. Method for rapid determination of alkaline phosphatase with 5 cubic millimeters of serum. J Biol Chem. 1946;164:321-329.
35. Landis WJ, Glimcher MJ. Electron diffraction and electron probe microanalysis of the mineral phase of bone tissue prepared by anhydrous techniques. J Ultrastruct Res. 1978;63:188-223.
36. McKee MD, Nanci A. Osteopontin at mineralized tissue interfaces in bone, teeth and osseointegrated implants: ultrastructural distribution and implications for mineralized tissue formation, turnover, and repair. Microsc Res Tech. 1996;33:141-164.
37. Whyte MP. Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev. 1994;15:439-461.
38. Tenenbaum HC. Levamisole and inorganic phosphate inhibit β-glycerophosphate induced mineralization of bone formed in vitro. Bone Miner. 1987;2:13-26.
39. Anderson HC. Matrix vesicle calcification: review and update. In: Peck W, ed. Bone and Mineral Research. New York, NY: Elsevier Science Publishers; 1985:109-149.
40. Schor AM, Canfield AE, Sutton AB, Arciniegas E, Allen TD. Pericyte differentiation. Clin Orthop. 1995;313:81-91.
41. Watson KE, Bostrom K, Ravindranath R, Lam T, Norton B, Demer LL. TGF-b1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest. 1994;93:2106-2113.
42. Balica M, Bostrom K, Shin V, Tillisch K, Demer LL. Calcifying sub-population of bovine aortic smooth muscle cells is responsive to 17β-estradiol. Circulation. 1997;95:1954-1960.
43. Parahami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berlinger JA, Demer LL. Lipid oxidation products have opposite effects on calcifying vascular cell and bone. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol. 1997;17:680-687.
44. Canfield AE, Sutton AB, Hoyland JA, Schor AM. Association of thrombospondin-1 with osteogenic differentiation of retinal pericytes in vitro. J Cell Sci. 1996;109:343-353.
45. Shen M, Marie P, Farge D, Carpentier S, De Pollak C, Hott M, Chen L, Martinet B, Carpentier A. Osteopontin is associated with bioprosthetic heart valve calcification in humans. C R Acad Sci III. 1997;320:49-57.
46. Gura TA, Wright KL, Veis A, Webb CL. Identification of specific calcium-binding noncollagenous proteins associated with glutaraldehyde-preserved bovine pericardium in the rat subdermal model. J Biomed Mater Res. 1997;35:483-495.
47. Srivatsa SS, Harrity PJ, Maerchlein PB, Kleppe L, Veinot J, Edwards WD, Johnson CM, Fitzpatrick LA. Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves. J Clin Invest. 1997;99:996-1009.
48. McKee MD, Nanci A. Osteopontin: an interfacial extracellular matrix protein in mineralized tissues. Connect Tissue Res. 1996;35:197-205.
49. Boskey AL. Matrix proteins and mineralization: an overview. Connect Tissue Res. 1996;35:357-363.
50. Chen Y, Bal BS, Gorski JP. Calcium and collagen binding properties of osteopontin, bone sialoprotein, and bone acidic glycoprotein-75 from bone. J Biol Chem. 1992;267:24871-24878.
51. Gorski JP, Kremer E, Ruiz-Perez J, Wise GE, Artigues A. Conformational analysis on soluble and surface bound osteopontin. Ann N Y Acad Sci. 1995;760:12-23.
52. Shiraga H, Min W, VanDusen WJ, Clayman MD, Miner D, Terrell CH, Sherbotie JR, Foreman JW, Przysiecki C, Neilson EG, Hoyer JR. Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci U S A. 1992;89:426-430.
53. Liaw L, Lindner V, Schwanz SM, Chambers AF, Giachelli CM. Osteopontin and β3 integrin are coordinately expressed in regenerating endothelium in vivo and stimulate RGD-dependent endothelial migration in vitro. Circ Res. 1995;77:665-672.
54. Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, Schwartz SM, Giachelli CM. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins: role of αvβ3 in smooth muscle migration to osteopontin. J Clin Invest. 1994;95:713-724.
55. Giachelli CM, Scatena M, Wada T. Osteopontin: potential roles in vascular function and dystrophic calcification. J Bone Miner Metab 1997;15:179-183.
56. Liaw L, Lombardi D, Almeida MM, Schwartz SM, deBlois D, Giachelli CM. Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening following endothelial denudation. Arterioscler Thromb Vasc Biol. 1997;17:188-193.
57. McKee MD, Nanci A. Secretion of osteopontin by macrophages and its accumulation at tissue surfaces during wound healing in mineralized tissues: a potential requirement for macrophage adhesion and phagocytosis. Anat Rec. 1996;245:394-409.
58. Singh K, Deonarine D, Shanmugam V, Senger DR. Calcium-binding properties of osteopontin derived from non-osteogenic sources. J Biochem (Tokyo). 1993;114:702-707.